Flexus Biosciences
Flexus Biosciences was a South San Francisco / San Carlos, California biotechnology company founded in 2013 to develop small-molecule cancer immunotherapies, most notably inhibitors of the IDO/TDO immunosuppressive pathway (lead IDO1 program F001287). Backed by Kleiner Perkins and The Column Group, it was acquired by Bristol-Myers Squibb in February 2015 for up to roughly $1.25 billion (about $800M upfront) to expand BMS's immuno-oncology pipeline. The company no longer operates independently; its domain redirects to the Bristol-Myers Squibb acquisition announcement. It publishes no public developer portal, documentation, or API, so this profile carries company identity only and no technical API artifacts.
Index entry only — little beyond a description and a link, and nothing machine-readable enough for an agent to act on without a human reading the site first.
Flexus Biosciences is tracked in the API Evangelist network. This page is the human-readable profile that sits on top of the machine-readable index we maintain at apis.io.
Every provider in the network is reduced to the same set of machine-readable artifacts — OpenAPI contracts, event specifications, GraphQL schemas, runnable collections, pricing and rate-limit signals, security posture, OAuth scopes, and the agent surfaces (MCP servers and skills) that let software drive the API on its own. We profile them because the interface is the part of a company you can actually inspect: it is a truer signal of what a provider does than any marketing page. From those artifacts we compute the Kin Score — Flexus Biosciences scores 5.7/100 (minimal), with a separate agent-readiness read of 0/100 (human only). The full breakdown is below, followed by every artifact we hold — each card links through to its machine-readable definition on apis.io.
Kin Score
This is the API Evangelist rating — a single, repeatable read computed from the artifacts on this page. Green fill is points earned; the red track is points possible, so every bar shows earned-versus-possible at a glance.
Kin Score
How this is scored →scored 2026-07-27 · rubric v0.5
Flexus Biosciences is in the network as a tracked entity. We haven't yet indexed a public API surface for it — when one is published, the artifacts, score, and agent-readiness read will appear here automatically. The source repository is where that profile is built.
← All providers · Data indexed from github.com/api-evangelist/flexus-biosciences · machine-readable index on apis.io